Touchlight - About the company
Touchlight is a series B company based in Hampton (United Kingdom), founded in 2007 by Jonny Ohlson. It operates as a Provider of cell-free DNA technology platform for genetic medicine application. Touchlight has raised $190M in funding from Novator Partners and Bridford Group, with a current valuation of $1B. The company has 147 active competitors, including 68 funded and 24 that have exited. Its top competitors include companies like Ginkgo Bioworks, Syngenta and Synthego.
Sectors and market segments that Touchlight operate in
Touchlight serves in the Life Sciences market segments.The primary business model of Touchlight is:Company Details
Provider of cell-free DNA technology platform for genetic medicine application. It leverages a proprietary technology platform and enzymatic manufacturing solutions to develop doggy bone DNA vectors optimized for use in advanced genetic medicines. The platform supports a range of applications which includes mRNA therapeutics, AAV and lentiviral vectors, gene editing, non‑viral therapies, and DNA vaccines.
- Website
- touchlight.com
- Social
- Email ID
- *****@touchlight.com
- Phone Number
- +44 **********
Key Metrics
Founded Year
2007
Location
Hampton, United Kingdom
Stage
Series B
Total Funding
$190M in 8 rounds
Latest Funding Round
Post Money Valuation
$1B as on Oct 21, 2021
Investors
Ranked
17th among 147 active competitors
Annual Revenue
£4.35M as on Dec 31, 2024
Employee Count
167 as on May 31, 2026
Similar Companies
Legal entities associated with Touchlight
Touchlight is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Touchlight Genetics Limited CIN: 6422158 , Germany, Active | Nov 07, 2007 | - | 57 (As on Dec 31, 2020) | |
TOUCHLIGHT HOLDINGS LIMITED CIN: 9272873 , United Kingdom, Active | Oct 20, 2014 | $5.56M (As on Dec 31, 2024) | 149 (As on Dec 31, 2023) |
Sign up to download Touchlight's company profile
Touchlight's funding and investors
Touchlight has raised a total funding of $190M over 8 rounds. Its first funding round was on Oct 30, 2014. Its latest funding round was a Grant (prize money) round on Sep 23, 2025 for $714K. 1 investor participated in its latest round. Touchlight has 14 institutional investors and 28 angel investors.
Here is the list of recent funding rounds of Touchlight:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 23, 2025 | $714K | Grant (prize money) | - | - | - | |
Nov 28, 2022 | Undisclosed | Grant (prize money) | - | - | - | |
Jan 07, 2021 | $179M | Series B | $777M | - | - |
Access funding benchmarks and valuations. Sign up today!View details of Touchlight's funding rounds and investors
Touchlight's founders and board of directors
Founder? Claim ProfileThe founders of Touchlight is Jonny Ohlson. Jonny Ohlson and Karen Fallen are the CEOs of Touchlight.
Here are the details of Touchlight's key team members:
- Jonny Ohlson: Founder & Co-CEO of Touchlight.
- Karen Fallen: Co-CEO of Touchlight. Contact Info: 1 email address
Touchlight's Board of Directors
Touchlight's board has 7 active members. Thomas Colum Harding, Ingo Olaf Eschweiler and Jonathan Keith Ohlson are part of team and Leopoldo Zambeletti, John Dwyer, David Edward Noel Lewis and Bradley James Theobald are independent board members.Here is the list of Touchlight's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 11y 6m | |
Investor | Bridford Group | Current | 5y 4m | |
Investor | Novator Partners | Current | 1y 7m | |
Independent board member | - | Current | 5y 0m | |
Independent board member | - | Current | 5y 6m | |
Independent board member | - | Current | 11y 3m | |
Independent board member | - | Current | 5y 7m |
View details of Touchlight's Founder profiles and Board Members
Touchlight's employee count trend
Touchlight has 167 employees as of May 26. Here is Touchlight's employee count trend over the years:
Uncover Touchlight's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Touchlight's Competitors and alternates
Top competitors of Touchlight include Ginkgo Bioworks, Syngenta and Synthego. Here is the list of Top 10 competitors of Touchlight, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Ginkgo Bioworks 2008, Boston (United States), Public | Autonomous labs for biotechnology, empowering scientists to design the living world | $796M | 81/100 | |
2nd |  Syngenta 2000, Basel (Switzerland), Acquired | Developer of technologies and sustainable farming practices for farmers | - | 75/100 | |
3rd | Synthego 2012, Redwood City (United States), Acquired | Developer of CRISPR-engineered cell and gene therapies | $460M | 71/100 | |
4th |  Twist Bioscience 2013, San Francisco (United States), Public | Developer of a semiconductor-based DNA synthesis platform | $321M | 70/100 | |
5th | Codexis 2002, Redwood City (United States), Public | Developer of high-performance enzymes for drug discovery | $111M | 68/100 | |
6th |  AskBio 2001, Durham (United States), Acquired | Developer of AAV technologies for treating genetic and complex disorders | $235M | 68/100 | |
7th | Amyris 2003, Emeryville (United States), Public | Developer of renewable products for industrial solutions | $487M | 68/100 | |
8th | Antheia 2013, Palo Alto (United States), Series C | Genetically engineered yeast cells to produce medicinal products | $176M | 67/100 | |
9th |  Asimov 2017, Boston (United States), Series B | Provider of integrated suite for advanced genetic design and manufacturing | $234M | 65/100 | |
10th |  Modalis Therapeutics 2016, Tokyo (Japan), Public | Developer of CRISPR based therapeutics for monogenic disorders | $60.7M | 63/100 | |
17th |  Touchlight 2007, Hampton (United Kingdom), Series B | Provider of cell-free DNA technology platform for genetic medicine application | $190M | 56/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Touchlight's competitors? Click here to see the top ones
Touchlight's Investments and acquisitions
Touchlight has made no investments or acquisitions yet.
Reports related to Touchlight
Here is the latest report on Touchlight's sector:
News related to Touchlight
Filter this listMedia has covered Touchlight for 1 event in last 1 year, It was about partnerships.
•
Touchlight, SVF Vaccines Partner to Advance Hepatitis B/D VaccineContract Pharma•Apr 09, 2026•SVF Vaccines, Touchlight
•
•
Touchlight, University of Nottingham Partner to Develop Zika DNA VaccineContract Pharma•Aug 22, 2024•Touchlight
•
Touchlight to supply GMP dbDNA for UK Zika vaccine studyPharmaceutical Technology•Aug 22, 2024•Touchlight, The University of Nottingham
•
•
LenioBio, Touchlight Enter Supply Agreement to Accelerate Development of Protein TherapeuticsContract Pharma•Jul 03, 2024•LenioBio, Touchlight
•
•
Touchlight joins forces with University of Liverpool for NSCLC vaccinePharmaceutical Technology•Apr 04, 2024•Touchlight, The University of Edinburgh
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Touchlight
Explore our recently published companies
- Grasmueck - Germany based, Unfunded company
- Bratanovic - Umag based, Unfunded company
- Guidepost-Strategy - Unfunded company
- Byronconsulting - Unfunded company
- Emanation - 2015 founded, Unfunded company
- CRM Masters - Gurugram based, 2014 founded, Unfunded company
